Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action

10.1016/j.bcp.2017.03.024

Saved in:
Bibliographic Details
Main Authors: Tan, WS Daniel, Liao, Wupeng, Zhou, Shuo, Wong, WS Fred
Other Authors: PHARMACOLOGY
Format: Article
Language:English
Published: PERGAMON-ELSEVIER SCIENCE LTD 2023
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/239319
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-239319
record_format dspace
spelling sg-nus-scholar.10635-2393192024-11-15T18:38:39Z Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action Tan, WS Daniel Liao, Wupeng Zhou, Shuo Wong, WS Fred PHARMACOLOGY Prof Wai-Shiu Fred Wong Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Asthma Hepatitis Neurodegeneration Autoimmune NF-kappa B Nrf2 NF-KAPPA-B INDUCED PULMONARY-FIBROSIS COMBINATION KAN-JANG CELL-CYCLE ARREST IN-VITRO COGNITIVE IMPAIRMENT PROTECTIVE ACTIVITY ALZHEIMERS-DISEASE SIGNALING PATHWAY OXIDATIVE STRESS 10.1016/j.bcp.2017.03.024 BIOCHEMICAL PHARMACOLOGY 139 71-81 2023-05-11T08:07:51Z 2023-05-11T08:07:51Z 2017-09-01 2023-05-11T06:09:24Z Article Tan, WS Daniel, Liao, Wupeng, Zhou, Shuo, Wong, WS Fred (2017-09-01). Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action. BIOCHEMICAL PHARMACOLOGY 139 : 71-81. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bcp.2017.03.024 0006-2952 1873-2968 https://scholarbank.nus.edu.sg/handle/10635/239319 en PERGAMON-ELSEVIER SCIENCE LTD Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
Asthma
Hepatitis
Neurodegeneration
Autoimmune
NF-kappa B
Nrf2
NF-KAPPA-B
INDUCED PULMONARY-FIBROSIS
COMBINATION KAN-JANG
CELL-CYCLE ARREST
IN-VITRO
COGNITIVE IMPAIRMENT
PROTECTIVE ACTIVITY
ALZHEIMERS-DISEASE
SIGNALING PATHWAY
OXIDATIVE STRESS
spellingShingle Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
Asthma
Hepatitis
Neurodegeneration
Autoimmune
NF-kappa B
Nrf2
NF-KAPPA-B
INDUCED PULMONARY-FIBROSIS
COMBINATION KAN-JANG
CELL-CYCLE ARREST
IN-VITRO
COGNITIVE IMPAIRMENT
PROTECTIVE ACTIVITY
ALZHEIMERS-DISEASE
SIGNALING PATHWAY
OXIDATIVE STRESS
Tan, WS Daniel
Liao, Wupeng
Zhou, Shuo
Wong, WS Fred
Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action
description 10.1016/j.bcp.2017.03.024
author2 PHARMACOLOGY
author_facet PHARMACOLOGY
Tan, WS Daniel
Liao, Wupeng
Zhou, Shuo
Wong, WS Fred
format Article
author Tan, WS Daniel
Liao, Wupeng
Zhou, Shuo
Wong, WS Fred
author_sort Tan, WS Daniel
title Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action
title_short Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action
title_full Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action
title_fullStr Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action
title_full_unstemmed Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action
title_sort is there a future for andrographolide to be an anti-inflammatory drug? deciphering its major mechanisms of action
publisher PERGAMON-ELSEVIER SCIENCE LTD
publishDate 2023
url https://scholarbank.nus.edu.sg/handle/10635/239319
_version_ 1821208505284034560